Repatha (evolocumab) 140 mg, 2 pre-filled pens Repatha (evolocumab) is used for hypercholesterolemia and mixed dyslipidemia in eligible patients. Medicine delivery from Europe within 4-5 days with storage conditions maintained. Order at +380996042415 via Viber or WhatsApp.

Hypercholesterolemia and mixed dyslipidemia

The drug Repatha is indicated for adults with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia as adjunctive therapy to diet:

• in combination with a statin or a statin and other lipid-lowering therapies for patients unable to achieve the desired LDL-C levels with the maximum tolerated dose of a statin, or
• alone or in combination with other lipid-lowering therapies for patients who are intolerant to statins or for whom statins are contraindicated.

Homozygous familial hypercholesterolemia

Repatha is indicated for adults and adolescents 12 years of age and older with homozygous familial hypercholesterolemia in combination with other lipid-lowering therapies.

Established atherosclerosis of the cardiovascular system

The drug Repatha is indicated in adults with established atherosclerosis of the cardiovascular system (myocardial infarction, stroke, or peripheral artery disease) to reduce cardiovascular risk by lowering LDL cholesterol, as an adjunct to the correction of other risk factors:

• in combination with the maximum tolerated dose of a statin with or without other lipid-lowering methods, or
• alone or in combination with other hypolipidemic types of therapy in patients with statin intolerance or in patients for whom a statin is contraindicated.